Prefer to view this content on our website? Click here.
Dear Fellow Investor,
Protect Your Portfolio with these Three High-Yielding ETFs
When markets get choppy, investors often scramble for safe havens. Some move into gold, others pile into bonds, and many simply sit in cash waiting for volatility to settle down. But there’s another powerful way to protect your portfolio from market turbulence—while getting paid handsomely in the process: high-yielding exchange-traded funds (ETFs).
High-yield ETFs provide a dual benefit. They keep you diversified across multiple income-generating assets, and they consistently pay out dividends that can either be reinvested for compounding or taken as steady income. For investors looking for both protection and returns, they’re among the best tools available.
One great example is the Global X Super Dividend ETF (SYM: SDIV), which currently sports a 9.57% yield and distributes dividends every month. In other words, SDIV pays investors just for holding the fund—while providing exposure to 100 of the highest dividend-paying stocks worldwide.
But SDIV isn’t the only option worth considering. Here’s a closer look at three high-yield ETFs that can help shield your portfolio from volatility while boosting your income stream.
ETF: Global X Super Dividend ETF (SYM: SDIV)
The Global X Super Dividend ETF (SYM: SDIV) has built its reputation as one of the market’s most attractive income vehicles. With an expense ratio of 0.58% and a 30-day yield nearing 10%, it’s designed for income-focused investors who want consistency and diversification.
The ETF tracks 100 of the world’s highest dividend-paying equities, spreading risk across different sectors and geographies. Current holdings include names like Bright Smart, SES, Delta Israel, and Ithaca Energy.
Another advantage is SDIV’s monthly payouts, which make it easier for investors who want regular cash flow—whether for reinvestment or living expenses. On August 12, the fund distributed 19 cents per share, with the next payment scheduled for September 11.
For those worried about market swings, SDIV’s broad exposure and strong yield provide both stability and income potential.
The Oxford Club
Hidden AI stock beats estimates 19%!
Nuclear stocks already up 51% as energy crisis hits. $947M cash flow company needs massive power. Smart money targets infrastructure + energy. Details →
ETF: Invesco KBW High Dividend Yield Financial ETF (SYM: KBWD)
Next up is the Invesco KBW High Dividend Yield Financial ETF (SYM: KBWD), which offers exposure to the income-rich financial sector. With an expense ratio of 0.35% and a 30-day yield of 12.28%, it’s one of the most generous ETFs in terms of payouts.
KBWD invests at least 90% of its assets in high-dividend financial stocks, including Orchid Island Capital, Invesco Mortgage Capital, ARMOUR Residential REIT, AGNC Investment, and Annaly Capital. This heavy weighting toward real estate investment trusts (REITs) and mortgage lenders explains its ultra-high yield.
Like SDIV, KBWD pays dividends monthly. On August 22, it distributed 14 cents per share, following a similar payout on July 25.
For investors who want to tap into the financial sector’s income potential without concentrating risk into a single stock, KBWD provides a diversified, yield-focused approach.
ETF: iShares Mortgage Real Estate ETF (SYM: REM)
For exposure to the U.S. mortgage market—both residential and commercial—there’s the iShares Mortgage Real Estate ETF (SYM: REM). With an expense ratio of 0.48% and a 30-day yield of 9.93%, REM is a strong choice for income-seekers.
Its holdings include Annaly Capital, AGNC Investment, Starwood Property, Arbor Realty Trust, ARMOUR Residential, and Dynex Capital REIT. Each of these companies operates in the real estate financing sector, generating substantial income from interest payments.
REM’s advantage lies in its focus on both residential and commercial mortgage REITs, which positions it to benefit from long-term real estate trends.
-
On the residential side, the U.S. housing market remains strong. According to Grand View Research, the market was worth $130 billion in 2024 and is projected to grow at a 4.1% CAGR from 2025 to 2030, fueled by population growth, urbanization, and millennial homeownership.
-
On the commercial side, JPMorgan expects 2025 to be a strong year for the industry, with industrial and multifamily properties leading the way, and even office vacancy rates beginning to stabilize.
With consistent monthly payouts—such as the 54 cents per share distributed on June 20—REM offers a compelling mix of yield and long-term growth exposure.
Trading Whisperer
From $1.03 to $8.30 — Why This Play Moves Fast
It’s rare to see a coffee stock with moves like this:
- January 2025: $1.03 → $6.70 (+550%)
- February 2025: $3.80 → $8.30 (+118%)
Both runs were sparked by modest headlines. The reason? A float of just 2.41 million shares — scarcity that turns small buying pressure into outsized gains.
But there’s more behind it than a tight share structure.
This premium coffee brand is fusing proprietary brewing science with AI-powered retail intelligence — integrating predictive upselling, smart staffing, and real-time sales optimization.
It’s using tech to not just sell more coffee, but to run more profitable locations, faster.
And while many micro-caps crawl toward expansion, this one is signing multi-country franchise deals in China, Malaysia, and the UAE before most investors even know the name.
Specialty coffee is the fastest-growing slice of a $101.6 billion market. Add AI into the mix, and you get a business that can scale quicker and smarter than its peers.
With a float this small, the next AI-driven growth update could send shares ripping again.
There’s also a timely opportunity in Vertex Pharmaceuticals (SYM: VRTX).
The biotech stock recently sold off after news that its pain drug VX-993 failed in a Phase 2 trial. But technical indicators suggest the stock may now be oversold. In past cases—April 2024, December 2024, and May 2025—VRTX bounced sharply after similar conditions.
Adding confidence, CEO Reshma Kewalramani just purchased 10,000 shares worth $3.9 million at around $390 per share. When executives put significant personal capital into their own company, it often signals long-term confidence.
For investors who can stomach biotech volatility, VRTX may present a buy-the-dip opportunity.
Stansberry Research
The Government Just Made a $400M Bet. Who's Next?
A $100 trillion wealth shift is quietly underway... and the government just confirmed it. The Pentagon just became the largest shareholder in MP Materials (NYSE: MP), locking in 100% of the company's rare-earth production for the next decade... and sending the stock soaring. According to former hedge fund manager Whitney Tilson, this is just the beginning. He's been warning this would happen: that the government would start monetizing America's hidden assets... land, energy, resources ... by backing select public companies. Now he believes he's found the $10 stock that could be next. It's already being scooped up by billionaire investors... and he's prepared to reveal the name and ticker... for free.
Click here for the full story.
Are there any other dividend paying stocks or ETFs you swear by? What specific sectors of the market are you most interested in right now? Hit "reply" to this email and let us know your thoughts!
No comments:
Post a Comment